San Diego, CA (PRWEB) December 24, 2012
AttorneyOne.com, a recognized authority on law, informs on the latest news concerning Nexium: On December 6th, 2012, 39 lawsuits alleging Nexium caused bone fractures were consolidated in the Multidistrict Litigation MDL 2404 (Central District of California) by the U.S. Judicial Panel. Nexium, manufactured by AstraZeneca, is a proton pump inhibitor (PPI) prescribed for the treatment of heartburn, acid-reflux, and inflammation of the esophagus.
Plaintiffs allege that Nexium may cause a variety of bone ailments —in particular, osteoporosis, loss of bone density, and bone fractures— and that AstraZeneca failed to adequately warn of these potential adverse side effects. AttorneyOne.com will provide all latest information on possible Nexium Recall lawsuits.
In April 2012, MHRA published an article revealing that there is recent epidemiological evidence of an increased risk of fracture with long-term use of PPIs (Proton Pump Inhibitors), including Nexium.
AttorneyOne.com can provide simple solutions including how to get in contact with legal counsel easily and inexpensively in case of Nexium severe complications. Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates the existence of alleged threat from Nexium. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
A study published on January 31st 2012, in the British Medical Journal, showed that postmenopausal women are at a 35% increased risk of hip fractures if they regularly use PPIs, including Nexium, and that
Copyright©2012 Vocus, Inc.
All rights reserved